Product Information
BELBUCA 300 MCG FILM is a brand product labeled by BioDelivery Sciences International Inc, priced at $11.8563 per EA under NDC 59385002360. Its NADAC has been published 467 times since Oct 25, 2017.
FDA first approved this application on Oct 23, 2015.
Strength
300 ug/1
Manufacturer
BioDelivery Sciences International IncNDC
59385002360
Classification
Brand
Dosage Form
FILM, SOLUBLE
Route
BUCCAL
Effective Date
9/23/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA207932FDA Approved
10/23/2015
On Market Since
9/1/2017
Pharmacological Classes
Price Statistics
The NADAC for BELBUCA 300 MCG FILM has been published 467 times since Oct 25, 2017, and over the history we have for it it has risen 69.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8563 per EA |
|---|---|
| All-time high | $11.8705 (May 13, 2026) |
| All-time low | $6.9901 (Oct 25, 2017) |
| 52-week high | $11.8705 |
| 52-week low | $11.3044 |
| Median price | $9.6543 |
| Average price | $9.5924 |
| Largest weekly change | +9.4% (Mar 20, 2019) |
| Weeks tracked | 467 |
| Tracking since | Oct 25, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the buprenorphine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BioDelivery Sciences International Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
buprenorphine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Partial Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BELBUCA 300 MCG FILM?
The current National Average Drug Acquisition Cost (NADAC) for BELBUCA 300 MCG FILM, manufactured by BioDelivery Sciences International Inc, is $11.8563 per EA (NDC 59385002360), effective Sep 30, 2026.
How has the price of BELBUCA 300 MCG FILM changed over time?
Over the history we have for it, the NADAC for BELBUCA 300 MCG FILM has risen 69.6%. It has been tracked across 467 weekly CMS publications since Oct 25, 2017.
What are the highest and lowest recorded NADAC prices for BELBUCA 300 MCG FILM?
Since Oct 25, 2017, the NADAC for BELBUCA 300 MCG FILM has ranged from a low of $6.9901 (Oct 25, 2017) to a high of $11.8705 (May 13, 2026), with a median of $9.6543 per EA.
Are there cheaper alternatives to BELBUCA 300 MCG FILM?
No other NADAC-published product currently shares the active ingredient and strength of BELBUCA 300 MCG FILM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BELBUCA 300 MCG FILM?
BELBUCA 300 MCG FILM (NDC 59385002360) is labeled by BioDelivery Sciences International Inc, and CMS classifies it as a brand product.